Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AGILENT TECHNOLOGIES, INC.A · Entity 3062 | Director | September 08, 2026 | September 10, 2026 |
| DEXCOM INCDXCM · Entity 3114 | Director | September 10, 2026 | September 10, 2026 |
| Inogen IncINGN · Entity 2083 | Director | June 05, 2026 | June 09, 2026 |
| STRYKER CORPSYK · Entity 369 | VP, Chief Financial Officer | March 21, 2025 | March 25, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AGILENT TECHNOLOGIES, INC.
Report date September 08, 2026 · Filed September 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 817 |
Reported balance
After 2026-09-08 transaction · row 1
1 source rowRow 1 · 2026-09-08 · Grant · Acquired 817 · Balance 817 F1: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. |
| Common StockSEC Table I · non-derivative | IndirectBoehnlein 2017 Trust | 35 |
Reported balance
Holding disclosure · report date 2026-09-08 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 35 F2: Shares held by the Boehnlein 2017 Trust for which Glenn and Susan Boehnlein are the trustees. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant.
F2: Shares held by the Boehnlein 2017 Trust for which Glenn and Susan Boehnlein are the trustees.
DEXCOM INC
Report date September 10, 2026 · Filed September 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,841 |
Reported balance
After 2026-09-10 transaction · row 1
1 source rowRow 1 · 2026-09-10 · Grant · Acquired 5,841 · Balance 5,841 F1: Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 42 |
Reported balance
Holding disclosure · report date 2026-09-10 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 42 F2: Shares are held by the Boehnlein 2017 Trust, with respect to which the Reporting Person and the Reporting Person's spouse are co-trustees. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
F2: Shares are held by the Boehnlein 2017 Trust, with respect to which the Reporting Person and the Reporting Person's spouse are co-trustees.
Inogen Inc
Report date June 05, 2026 · Filed June 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 104,966 |
Reported balance
After 2026-06-05 transaction · row 1
1 source rowRow 1 · 2026-06-05 · Grant · Acquired 28,081 · Balance 104,966 F1: The reported shares were acquired pursuant to a restricted stock unit award. Subject to the reporting person's continued service, the restricted stock unit award shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported shares were acquired pursuant to a restricted stock unit award. Subject to the reporting person's continued service, the restricted stock unit award shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant.
STRYKER CORP
Report date March 21, 2025 · Filed March 25, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,638 |
Ending reported balance
After 2025-03-21 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-03-21 · Exercise / conversion · Acquired 314 · Balance 18,358 F1: On March 12, 2025, the Reporting Person filed a Form 4 reporting the acquisition of 12,916 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2025 (the "Performance Stock Units"). The 314 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2025 and were settled for an equal number of shares of Stryker Common Stock. Row 2 · 2025-03-21 · Tax withholding · Disposed 6,720 · Balance 11,638 |
| Dividend EquivalentsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-03-21 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-03-21 · Exercise / conversion · Disposed 314 · Balance 0 F1: On March 12, 2025, the Reporting Person filed a Form 4 reporting the acquisition of 12,916 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2025 (the "Performance Stock Units"). The 314 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2025 and were settled for an equal number of shares of Stryker Common Stock. |
| Common StockSEC Table I · non-derivative | IndirectBy 401K | 1,557 |
Reported balance
Holding disclosure · report date 2025-03-21 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,557 |
Filing footnotes · ownership attribution and instrument terms
F1: On March 12, 2025, the Reporting Person filed a Form 4 reporting the acquisition of 12,916 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2025 (the "Performance Stock Units"). The 314 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2025 and were settled for an equal number of shares of Stryker Common Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 10, 2026 Filed Sep 10, 2026 20:40 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 5,841 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000171 · wk-form4_1789072814.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,841 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 12:52 UTC | AGILENT TECHNOLOGIES, INC. A · Entity 3062 | GrantCommon Stock | 817 | $146.85 | $119,976.45 |
DisclosureSEC source: 0001090872-26-000067 · form4.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 817 F1 · price: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 16:21 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 28,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001670936-26-000004 · ownership.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,966 F1 · shares: The reported shares were acquired pursuant to a restricted stock unit award. Subject to the reporting person's continued service, the restricted stock unit award shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant. Read SEC document |
| May 14, 2025 Filed May 19, 2025 08:53 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 30,612 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-073975 · ownership.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,885 F1 · shares: The reported shares were acquired pursuant to a restricted stock unit award. Subject to the reporting person's continued service, the restricted stock unit award shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 20:20 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionDividend Equivalents · Derivative | 314 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-25-000055 · wk-form4_1742934018.xml · derivative · entry 4 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 314 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On March 12, 2025, the Reporting Person filed a Form 4 reporting the acquisition of 12,916 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2025 (the "Performance Stock Units"). The 314 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2025 and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.exercise_date: On March 12, 2025, the Reporting Person filed a Form 4 reporting the acquisition of 12,916 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2025 (the "Performance Stock Units"). The 314 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2025 and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.expiration_date: On March 12, 2025, the Reporting Person filed a Form 4 reporting the acquisition of 12,916 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2025 (the "Performance Stock Units"). The 314 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2025 and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 20:20 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 6,720 | $374.22 | $2,514,758.40 |
DisclosureSEC source: 0000310764-25-000055 · wk-form4_1742934018.xml · nonDerivative · entry 2 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,638 Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 20:20 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 314 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-25-000055 · wk-form4_1742934018.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,358 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On March 12, 2025, the Reporting Person filed a Form 4 reporting the acquisition of 12,916 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2025 (the "Performance Stock Units"). The 314 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2025 and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 20:52 UTC | STRYKER CORP SYK · Entity 369 | GrantCommon Stock | 12,916 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-25-000033 · wk-form4_1741812754.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,044 F1 · kind: Acquired upon the achievement of pre-established three-year adjusted diluted net earnings per share goals and sales performance goals. The earned shares vest on March 21, 2025. Read SEC document |
| December 31, 2024 Filed Jan 2, 2025 21:44 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionEmployee Stock Option granted 2/8/2017 (right to buy) · Derivative | 300 | $0.00 Strike: $122.51 | $0.00 |
DisclosureSEC source: 0000310764-25-000002 · wk-form4_1735854281.xml · derivative · entry 4 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,015 Underlying: Common Stock · 300 shares Expires 2027-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| December 31, 2024 Filed Jan 2, 2025 21:44 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 203 | $362.26 | $73,538.78 |
DisclosureSEC source: 0000310764-25-000002 · wk-form4_1735854281.xml · nonDerivative · entry 2 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,128 Read SEC document |
| December 31, 2024 Filed Jan 2, 2025 21:44 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 300 | $122.51 | $36,753.00 |
DisclosureSEC source: 0000310764-25-000002 · wk-form4_1735854281.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 27, 2024 Filed Dec 30, 2024 21:19 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionEmployee Stock Option granted 2/8/2017 (right to buy) · Derivative | 2,000 | $0.00 Strike: $122.51 | $0.00 |
DisclosureSEC source: 0000310764-24-000125 · wk-form4_1735593548.xml · derivative · entry 4 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,315 Underlying: Common Stock · 2,000 shares Expires 2027-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| December 27, 2024 Filed Dec 30, 2024 21:19 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 1,342 | $369.42 | $495,761.64 |
DisclosureSEC source: 0000310764-24-000125 · wk-form4_1735593548.xml · nonDerivative · entry 2 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,031 Read SEC document |
| December 27, 2024 Filed Dec 30, 2024 21:19 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 2,000 | $122.51 | $245,020.00 |
DisclosureSEC source: 0000310764-24-000125 · wk-form4_1735593548.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,373 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 21:36 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionEmployee Stock Option granted 2/8/2017 (right to buy) · Derivative | 4,500 | $0.00 Strike: $122.51 | $0.00 |
DisclosureSEC source: 0000310764-24-000120 · wk-form4_1732052210.xml · derivative · entry 4 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,315 Underlying: Common Stock · 4,500 shares Expires 2027-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 21:36 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 2,979 | $390.08 | $1,162,048.32 |
DisclosureSEC source: 0000310764-24-000120 · wk-form4_1732052210.xml · nonDerivative · entry 2 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,373 Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 21:36 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 4,500 | $122.51 | $551,295.00 |
DisclosureSEC source: 0000310764-24-000120 · wk-form4_1732052210.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2024 Filed Aug 2, 2024 20:17 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 20,000 | $333.00 | $6,660,000.00 |
DisclosureSEC source: 0000310764-24-000100 · wk-form4_1722629828.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,852 Read SEC document |
| July 02, 2024 Filed Jul 3, 2024 20:33 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionEmployee Stock Option granted 2/8/2017 (right to buy) · Derivative | 25,000 | $0.00 Strike: $122.51 | $0.00 |
DisclosureSEC source: 0000310764-24-000090 · wk-form4_1720038790.xml · derivative · entry 4 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,815 Underlying: Common Stock · 25,000 shares Expires 2027-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| July 02, 2024 Filed Jul 3, 2024 20:33 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 17,160 | $336.50 | $5,774,340.00 |
DisclosureSEC source: 0000310764-24-000090 · wk-form4_1720038790.xml · nonDerivative · entry 2 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,852 Read SEC document |
| July 02, 2024 Filed Jul 3, 2024 20:33 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 25,000 | $122.51 | $3,062,750.00 |
DisclosureSEC source: 0000310764-24-000090 · wk-form4_1720038790.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 17:21 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 21,871 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-070904 · ownership.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,273 F1 · shares: The reported shares wee acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting schedule. Read SEC document |
| May 15, 2024 Filed May 16, 2024 20:16 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 10,000 | $327.65 | $3,276,516.00 |
DisclosureSEC source: 0000310764-24-000084 · wk-form4_1715890590.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,012 F1 · price: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $327.55 to $328.315, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:32 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 585 | $336.50 | $196,852.50 |
DisclosureSEC source: 0000310764-24-000066 · wk-form4_1714768358.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,012 Read SEC document |
| March 21, 2024 Filed Mar 25, 2024 22:45 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionDividend Equivalents · Derivative | 256 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-24-000036 · wk-form4_1711406719.xml · derivative · entry 4 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 256 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On March 13, 2024, the Reporting Person filed a Form 4 reporting the acquisition of 10,702 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2024 (the "Performance Stock Units"). The 256 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2024 and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.exercise_date: On March 13, 2024, the Reporting Person filed a Form 4 reporting the acquisition of 10,702 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2024 (the "Performance Stock Units"). The 256 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2024 and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.expiration_date: On March 13, 2024, the Reporting Person filed a Form 4 reporting the acquisition of 10,702 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2024 (the "Performance Stock Units"). The 256 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2024 and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| March 21, 2024 Filed Mar 25, 2024 22:45 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 5,555 | $353.19 | $1,961,970.45 |
DisclosureSEC source: 0000310764-24-000036 · wk-form4_1711406719.xml · nonDerivative · entry 2 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,597 Read SEC document |
| March 21, 2024 Filed Mar 25, 2024 22:45 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 256 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-24-000036 · wk-form4_1711406719.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On March 13, 2024, the Reporting Person filed a Form 4 reporting the acquisition of 10,702 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2024 (the "Performance Stock Units"). The 256 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2024 and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:23 UTC | STRYKER CORP SYK · Entity 369 | GrantCommon Stock | 10,702 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-24-000026 · wk-form4_1710361412.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,896 F1 · kind: Acquired upon the achievement of pre-established three-year adjusted diluted net earnings per share goals and sales performance goals. The earned shares vest on March 21, 2024. Read SEC document |
| February 09, 2024 Filed Feb 12, 2024 21:09 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 9,600 | $342.81 | $3,290,952.00 |
DisclosureSEC source: 0000310764-24-000022 · wk-form4_1707772142.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,194 F1 · price: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $342.80 to $342.86, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 21:46 UTC | STRYKER CORP SYK · Entity 369 | GrantEmployee Stock Option granted 02/07/2024 (right to buy) · Derivative | 21,190 | $0.00 Strike: $339.77 | $0.00 |
DisclosureSEC source: 0000310764-24-000015 · wk-form4_1707515178.xml · derivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,190 Underlying: Common Stock · 21,190 shares Expires 2034-02-06 F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| January 11, 2024 Filed Jan 16, 2024 21:16 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionEmployee Stock Option granted 02/10/2016 (right to buy) · Derivative | 49,150 | $0.00 Strike: $96.64 | $0.00 |
DisclosureSEC source: 0000310764-24-000001 · wk-form4_1705439754.xml · derivative · entry 6 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 49,150 shares Expires 2026-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| January 11, 2024 Filed Jan 16, 2024 21:16 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionEmployee Stock Option granted 02/11/2015 (right to buy) · Derivative | 10,855 | $0.00 Strike: $93.06 | $0.00 |
DisclosureSEC source: 0000310764-24-000001 · wk-form4_1705439754.xml · derivative · entry 5 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,855 shares Expires 2025-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| January 11, 2024 Filed Jan 16, 2024 21:16 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 39,187 | $307.78 | $12,060,974.86 |
DisclosureSEC source: 0000310764-24-000001 · wk-form4_1705439754.xml · nonDerivative · entry 3 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,794 Read SEC document |
| January 11, 2024 Filed Jan 16, 2024 21:16 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 49,150 | $96.64 | $4,749,856.00 |
DisclosureSEC source: 0000310764-24-000001 · wk-form4_1705439754.xml · nonDerivative · entry 2 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,981 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 11, 2024 Filed Jan 16, 2024 21:16 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 10,855 | $93.06 | $1,010,166.30 |
DisclosureSEC source: 0000310764-24-000001 · wk-form4_1705439754.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,831 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 01:02 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionEmployee Stock Option granted 02/12/2014 (right to buy) · Derivative | 11,955 | $0.00 Strike: $81.14 | $0.00 |
DisclosureSEC source: 0000310764-23-000122 · wk-form4_1701219710.xml · derivative · entry 4 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,955 shares Expires 2024-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 01:02 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 7,594 | $293.64 | $2,229,902.16 |
DisclosureSEC source: 0000310764-23-000122 · wk-form4_1701219710.xml · nonDerivative · entry 2 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,976 Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 01:02 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 11,955 | $81.14 | $970,028.70 |
DisclosureSEC source: 0000310764-23-000122 · wk-form4_1701219710.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,570 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 19:30 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 17,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-034059 · doc4.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,402 F1 · shares: The reported shares were acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting date. Read SEC document |
| May 01, 2023 Filed May 3, 2023 21:49 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 572 | $299.65 | $171,399.80 |
DisclosureSEC source: 0000310764-23-000069 · wf-form4_168315053517077.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,615 Read SEC document |
| March 21, 2023 Filed Mar 23, 2023 22:47 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionDividend Equivalents · Derivative | 149 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-23-000040 · wf-form4_167961163013311.xml · derivative · entry 4 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 149 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On March 9, 2023, the Reporting Person filed a Form 4 reporting the acquisition of 5,325 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2023 (the "Performance Stock Units"). The 149 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2023 and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.exercise_date: On March 9, 2023, the Reporting Person filed a Form 4 reporting the acquisition of 5,325 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2023 (the "Performance Stock Units"). The 149 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2023 and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.expiration_date: On March 9, 2023, the Reporting Person filed a Form 4 reporting the acquisition of 5,325 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2023 (the "Performance Stock Units"). The 149 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2023 and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| March 21, 2023 Filed Mar 23, 2023 22:47 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 2,715 | $276.83 | $751,593.45 |
DisclosureSEC source: 0000310764-23-000040 · wf-form4_167961163013311.xml · nonDerivative · entry 2 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,187 Read SEC document |
| March 21, 2023 Filed Mar 23, 2023 22:47 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 149 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-23-000040 · wf-form4_167961163013311.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,902 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On March 9, 2023, the Reporting Person filed a Form 4 reporting the acquisition of 5,325 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2023 (the "Performance Stock Units"). The 149 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2023 and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 22:51 UTC | STRYKER CORP SYK · Entity 369 | GrantCommon Stock | 5,325 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-23-000031 · wf-form4_167840226712147.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,753 F1 · kind: Acquired upon the achievement of pre-established three-year adjusted diluted net earnings per share goals and sales performance goals. The earned shares vest on March 21, 2023. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:02 UTC | STRYKER CORP SYK · Entity 369 | GrantEmployee Stock Option granted 02/09/2023 (right to buy) · Derivative | 30,570 | $0.00 Strike: $268.22 | $0.00 |
DisclosureSEC source: 0000310764-23-000022 · wf-form4_167632568872129.xml · derivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,570 Underlying: Common Stock · 30,570 shares Expires 2033-02-08 F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 23:17 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 125 | $279.96 | $34,995.25 |
DisclosureSEC source: 0000310764-23-000008 · wf-form4_167572544327722.xml · nonDerivative · entry 4 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,428 F4 · price: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $279.96 to $279.97, inclusive. The reporting person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 23:17 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 8,883 | $279.52 | $2,482,968.17 |
DisclosureSEC source: 0000310764-23-000008 · wf-form4_167572544327722.xml · nonDerivative · entry 3 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,553 F3 · price: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $278.94 to $279.92, inclusive. The reporting person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 23:17 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 7,708 | $278.38 | $2,145,725.29 |
DisclosureSEC source: 0000310764-23-000008 · wf-form4_167572544327722.xml · nonDerivative · entry 2 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,436 F2 · price: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $277.94 to $278.935, inclusive. The reporting person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 23:17 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 7,709 | $277.55 | $2,139,666.87 |
DisclosureSEC source: 0000310764-23-000008 · wf-form4_167572544327722.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,144 F1 · price: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $276.92 to $277.82, inclusive. The reporting person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. Read SEC document |
| January 11, 2023 Filed Jan 13, 2023 00:30 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionEmployee Stock Option granted 02/13/2013 (right to buy) · Derivative | 14,515 | $0.00 Strike: $64.01 | $0.00 |
DisclosureSEC source: 0000310764-23-000002 · wf-form4_167356983850119.xml · derivative · entry 4 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,515 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2006 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.